McKesson ( McKesson )


McKesson's picture

About McKesson

McKesson is in business for better health. As a company working with health care stakeholders in every setting, we are charting the course toward a stronger, more sustainable future for the entire industry.

As the oldest and largest health care services company in the nation, McKesson plays an integral role in health care and has a unique vision for its future. We serve more than 50% of American hospitals, 20% of physicians and 100% of health plans, and as the largest pharmaceutical distributor in North America, we deliver one-third of all medications used there every day.

Our software, automation technology, distribution and business services play an essential role in addressing the challenges health care organizations face today — and shaping how they’ll overcome them tomorrow. We connect people and organizations, support the quest for higher quality and improved clinical outcomes, and help health care businesses run better. And that supports better patient health.

McKesson press release, blog etc

08/15/2018 - 15:32 Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer
08/06/2018 - 04:16 Progressive Care Integrates with Illinois Cancer Specialists to Join The US Oncology Network
07/30/2018 - 23:21 McKesson Appoints Brian Tyler as President and Chief Operating Officer
07/23/2018 - 09:49 TIBSOVO (ivosidenib), an IDH1 Inhibitor Approved for Treatment of Relapsed/Refractory Acute Myeloid Leukemia with an IDH1 Mutation, Available for Order at Biologics, Inc.
07/17/2018 - 19:46 The US Oncology Network Promotes Leader in Value-Based Care Dr. Marcus Neubauer to Chief Medical Officer
07/09/2018 - 09:06 The US Oncology Network Welcomes Breast Surgeon Dr. Loren Rourke to a New Role as Chief Surgical Officer
07/09/2018 - 08:35 Power of Community Pharmacies Showcased at McKesson ideaShare
06/29/2018 - 20:27 Bartles Pharmacy Receives McKessons Pharmacy of the Year Award
06/29/2018 - 19:19 Combination Therapy BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the Treatment of BRAF-mutant Melanoma, Available for Order at Biologics, Inc.
06/29/2018 - 18:32 McKesson Debuts Drug Spend Savings Technology at HFMA
06/25/2018 - 21:50 McKesson Ventures Donates $10,000 to Meals on Wheels America on Behalf of Landmark Health
05/30/2018 - 11:54 Oncologists from The US Oncology Network and US Oncology Research to Present Data from More Than 40 Abstracts During the 54th Annual ASCO Meeting
05/29/2018 - 13:23 McKesson Corporation to Present at the Goldman Sachs 39th Annual Global Healthcare Conference and Host Investor Day
05/29/2018 - 12:23 TAVALISSE (fostamatinib disodium hexahydrate) Approved by FDA, Available for Order at Biologics, Inc.
05/16/2018 - 14:09 Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug
05/07/2018 - 13:31 Texas Oncology Receives 2018 PBMI Excellence Award for Care Management Strategies
05/07/2018 - 13:05 McKesson ideaShare: The Independents Power to Perform
04/30/2018 - 05:34 McKesson Board of Directors Elects Brad Lerman as New Independent Director